Cargando…
MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer’s disease
BACKGROUND: Matrix metallopeptidase 9 (MMP9) has been implicated in a variety of neurological disorders, including Alzheimer’s disease (AD), where MMP9 levels are elevated in the brain and cerebrovasculature. Previously our group demonstrated apolipoprotein E4 (apoE4) was less efficient in regulatin...
Autores principales: | Ringland, Charis, Schweig, Jonas Elias, Eisenbaum, Maxwell, Paris, Daniel, Ait-Ghezala, Ghania, Mullan, Michael, Crawford, Fiona, Abdullah, Laila, Bachmeier, Corbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8152085/ https://www.ncbi.nlm.nih.gov/pubmed/34034683 http://dx.doi.org/10.1186/s12868-021-00643-2 |
Ejemplares similares
-
Alzheimer’s disease pathological lesions activate the spleen tyrosine kinase
por: Schweig, Jonas Elias, et al.
Publicado: (2017) -
Amelioration of Experimental Autoimmune Encephalomyelitis by Anatabine
por: Paris, Daniel, et al.
Publicado: (2013) -
Flavonoids lower Alzheimer's Aβ production via an NFκB dependent mechanism
por: Paris, Daniel, et al.
Publicado: (2011) -
Mural cell dysfunction leads to altered cerebrovascular tau uptake following repetitive head trauma
por: Ojo, Joseph, et al.
Publicado: (2020) -
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
por: Ojo, Joseph O., et al.
Publicado: (2021)